Reassessing the Role of Regular Physical Examination in Post-treatment Breast Cancer Surveillance.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
3337 patients, 131 recurrences (3.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Most clinically meaningful recurrences were identified by imaging or patient self-report. These findings support survivorship strategies that prioritize imaging adherence and structured symptom assessment, with less emphasis on routine physical examination as a primary detection modality.
[BACKGROUND] Routine provider-performed physical examinations remain a standard element of breast cancer survivorship despite increasing evidence that diagnostic yield is limited.
APA
Levine A, Terrian L, et al. (2026). Reassessing the Role of Regular Physical Examination in Post-treatment Breast Cancer Surveillance.. Annals of surgical oncology. https://doi.org/10.1245/s10434-026-19227-7
MLA
Levine A, et al.. "Reassessing the Role of Regular Physical Examination in Post-treatment Breast Cancer Surveillance.." Annals of surgical oncology, 2026.
PMID
41680581 ↗
Abstract 한글 요약
[BACKGROUND] Routine provider-performed physical examinations remain a standard element of breast cancer survivorship despite increasing evidence that diagnostic yield is limited. With growing survivorship populations and mounting demands on oncology services, reassessment of the value of this practice is warranted. This study sought to evaluate the diagnostic yield and prognostic relevance of surveillance physical exams.
[METHODS] A retrospective review was conducted of women with breast cancer treated between January 2019 and December 2023 at a single tertiary center. Surgical oncology survivorship visits >90 days postoperatively were analyzed. Recurrence events were categorized by initial detection modality: provider-performed physical examination, patient-reported, screening imaging, or symptom-prompted non-breast imaging.
[RESULTS] Among 3337 patients, 131 recurrences (3.9%) occurred after a median of 20 months. Patients collectively attended 12,840 survivorship visits; only eight recurrences (6.1% of all recurrences; 0.06% of examinations) were first detected by physical examination. By comparison, 32 (24.4%) were patient-reported, 38 (29.0%) were detected on screening imaging, and 53 (40.5%) were identified by non-breast diagnostic imaging. When stratified by detection method, exam-detected recurrences were evenly divided between locoregional and combined locoregional/distant disease, whereas patient-reported and screening-detected recurrences were predominantly locoregional, at 72% and 92%, respectively.
[CONCLUSIONS] Breast and chest wall examinations accounted for a small proportion of recurrence detections despite thousands of survivorship visits annually. Most clinically meaningful recurrences were identified by imaging or patient self-report. These findings support survivorship strategies that prioritize imaging adherence and structured symptom assessment, with less emphasis on routine physical examination as a primary detection modality.
[METHODS] A retrospective review was conducted of women with breast cancer treated between January 2019 and December 2023 at a single tertiary center. Surgical oncology survivorship visits >90 days postoperatively were analyzed. Recurrence events were categorized by initial detection modality: provider-performed physical examination, patient-reported, screening imaging, or symptom-prompted non-breast imaging.
[RESULTS] Among 3337 patients, 131 recurrences (3.9%) occurred after a median of 20 months. Patients collectively attended 12,840 survivorship visits; only eight recurrences (6.1% of all recurrences; 0.06% of examinations) were first detected by physical examination. By comparison, 32 (24.4%) were patient-reported, 38 (29.0%) were detected on screening imaging, and 53 (40.5%) were identified by non-breast diagnostic imaging. When stratified by detection method, exam-detected recurrences were evenly divided between locoregional and combined locoregional/distant disease, whereas patient-reported and screening-detected recurrences were predominantly locoregional, at 72% and 92%, respectively.
[CONCLUSIONS] Breast and chest wall examinations accounted for a small proportion of recurrence detections despite thousands of survivorship visits annually. Most clinically meaningful recurrences were identified by imaging or patient self-report. These findings support survivorship strategies that prioritize imaging adherence and structured symptom assessment, with less emphasis on routine physical examination as a primary detection modality.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (2)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Early local immune activation following intra-operative radiotherapy in human breast tissue.
- Overall survival and prognostic factors in young women with breast cancer: a retrospective cohort study from Southern Thailand.
- Age at First Pregnancy, Adult Weight Gain and Postmenopausal Breast Cancer Risk: The PROCAS Study (United Kingdom).
- Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.
- Structural determinants of glycosaminoglycan oligosaccharides as LL-37 inhibitors in breast cancer.
- Artificial intelligence and breast cancer screening in Serbia: a dual-perspective qualitative study among radiologists and screening-aged women.